• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DDR1和DVL1在浸润性导管癌和小叶癌中的表达与组织学类型、分级及激素受体状态无关。

Expression of DDR1 and DVL1 in invasive ductal and lobular breast carcinoma does not correlate with histological type, grade and hormone receptor status.

作者信息

Ameli Fereshteh, Rose Isa Mohd, Masir Noraidah

机构信息

Departmentof Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia E-mail :

出版信息

Asian Pac J Cancer Prev. 2015;16(6):2385-90. doi: 10.7314/apjcp.2015.16.6.2385.

DOI:10.7314/apjcp.2015.16.6.2385
PMID:25824769
Abstract

BACKGROUND

Invasive ductal (IDC) and lobular (ILC) carcinomas are the common histological types of breast carcinoma which are difficult to distinguish when poorly differentiated. Discoidin domain receptor (DDR1) and Drosophila dishevelled protein (DVL1) were recently suggested to differentiate IDC from ILC.

OBJECTIVES

To assess the expression of DDR1 and DVL1 and their association with histological type, grading and hormonal status of IDC and ILC.

MATERIALS AND METHODS

This cross sectional study was conducted on IDC and ILC breast tumours. Tumours were immunohistochemically stained for (DDR1) and (DVL1) as well as estrogen receptor (ER), progesterone receptor (PR) and C-erbB2 receptor. Demographic data including age and ethnicity were obtained from patient records.

RESULTS

A total of 51 cases (30 IDCs and 21 ILCs) were assessed. DDR1 and DVL1 expression was not significantly associated with histological type (p=0.57 and p=0.66 respectively). There was no association between DDR1 and DVL1 expression and tumour grade (p=0.32 and p=1.00 respectively), ER (p=0.62 and 0.50 respectively), PR (p=0.38 and p=0.63 respectively) and C-erbB2 expression (p=0.19 and p=0.33 respectively) in IDC. There was no association between DDR1 and DVL1 expression and tumour grade (p=0.52 and p=0.33 respectively), ER (p=0.06 and p=0.76 respectively), PR (p=0.61 and p=0.43 respectively) and C-erbB2 expression (p=0.58 and p=0.76 respectively) in ILC.

CONCLUSIONS

This study revealed that DDR1 and DVL1 are present in both IDC and ILC regardless of the tumour differentiation. More studies are needed to assess the potential of these two proteins in distinguishing IDC from ILC in breast tumours.

摘要

背景

浸润性导管癌(IDC)和小叶癌(ILC)是乳腺癌常见的组织学类型,低分化时难以区分。盘状结构域受体(DDR1)和果蝇蓬乱蛋白(DVL1)最近被认为可用于区分IDC和ILC。

目的

评估DDR1和DVL1的表达及其与IDC和ILC的组织学类型、分级及激素状态的关系。

材料与方法

对IDC和ILC乳腺肿瘤进行了这项横断面研究。肿瘤进行了DDR1、DVL1以及雌激素受体(ER)、孕激素受体(PR)和C-erbB2受体的免疫组化染色。从患者记录中获取包括年龄和种族在内的人口统计学数据。

结果

共评估了51例病例(30例IDC和21例ILC)。DDR1和DVL1表达与组织学类型无显著相关性(分别为p = 0.57和p = 0.66)。在IDC中,DDR1和DVL1表达与肿瘤分级(分别为p = 0.32和p = 1.00)、ER(分别为p = 0.62和0.50)、PR(分别为p = 0.38和p = 0.63)以及C-erbB2表达(分别为p = 0.19和p = 0.33)均无相关性。在ILC中,DDR1和DVL1表达与肿瘤分级(分别为p = 0.52和p = 0.33)、ER(分别为p = 0.06和p = 0.76)、PR(分别为p = 0.61和p = 0.43)以及C-erbB2表达(分别为p = 0.58和p = 0.76)均无相关性。

结论

本研究表明,无论肿瘤分化程度如何,DDR1和DVL1在IDC和ILC中均有表达。需要更多研究来评估这两种蛋白在乳腺肿瘤中区分IDC和ILC的潜力。

相似文献

1
Expression of DDR1 and DVL1 in invasive ductal and lobular breast carcinoma does not correlate with histological type, grade and hormone receptor status.DDR1和DVL1在浸润性导管癌和小叶癌中的表达与组织学类型、分级及激素受体状态无关。
Asian Pac J Cancer Prev. 2015;16(6):2385-90. doi: 10.7314/apjcp.2015.16.6.2385.
2
Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.(18)F-FDG PET/CT标准化摄取值与浸润性小叶癌预后因素的相关性:与浸润性导管癌的比较
World J Surg Oncol. 2015 Mar 15;13:113. doi: 10.1186/s12957-015-0522-9.
3
Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.浸润性小叶癌转移的特定部位:转移性乳腺癌的一项回顾性队列研究
Breast Cancer. 2017 Sep;24(5):667-672. doi: 10.1007/s12282-017-0753-4. Epub 2017 Jan 20.
4
Survival analysis in patients with invasive lobular cancer and invasive ductal cancer according to hormone receptor expression status in the Korean population.根据韩国人群中激素受体表达状态分析浸润性小叶癌和浸润性导管癌患者的生存情况。
PLoS One. 2022 Jan 20;17(1):e0262709. doi: 10.1371/journal.pone.0262709. eCollection 2022.
5
Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.乳腺浸润性小叶癌与浸润性导管癌辅助化疗的相对疗效
Cancer. 2017 Aug 15;123(16):3015-3021. doi: 10.1002/cncr.30699. Epub 2017 Apr 5.
6
The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.根据乳腺癌的分子亚型,评估浸润性导管癌、小叶癌和混合性导管及小叶癌的预后。
Breast Cancer. 2021 Jan;28(1):187-195. doi: 10.1007/s12282-020-01146-4. Epub 2020 Aug 18.
7
Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.浸润性小叶癌与导管癌新辅助化疗的反应及手术管理差异
Ann Surg Oncol. 2016 Jan;23(1):51-7. doi: 10.1245/s10434-015-4603-3. Epub 2015 May 16.
8
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.通过激光显微切割和微阵列分析鉴别小叶型和导管型浸润性乳腺癌的新型标志物
BMC Cancer. 2007 Mar 27;7:55. doi: 10.1186/1471-2407-7-55.
9
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.可靶向的 ERBB2 突变状态是雌激素受体阳性、ERBB2 非扩增原发性小叶乳腺癌不良预后的独立标志物:公共数据集的回顾性计算机分析。
Breast Cancer Res. 2020 Aug 11;22(1):85. doi: 10.1186/s13058-020-01324-4.
10
Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.乳腺浸润性导管癌、浸润性小叶癌及混合性(浸润性导管 + 浸润性小叶)癌的临床病理特征比较。
Breast Cancer. 2015 Jul;22(4):374-81. doi: 10.1007/s12282-013-0489-8. Epub 2013 Aug 8.

引用本文的文献

1
Clinical significance of immunohistochemical expression of DDR1 and β-catenin in colorectal carcinoma.DDR1 和 β-连环蛋白在结直肠癌中的免疫组化表达的临床意义。
World J Surg Oncol. 2023 Jun 5;21(1):168. doi: 10.1186/s12957-023-03041-6.
2
Decoding the Role of DVL1 in Intracranial Meningioma.解析 DVL1 在颅内脑膜瘤中的作用。
Int J Mol Sci. 2021 Nov 5;22(21):11996. doi: 10.3390/ijms222111996.
3
Discoidin domain receptor 1: New star in cancer-targeted therapy and its complex role in breast carcinoma.盘状结构域受体1:癌症靶向治疗中的新星及其在乳腺癌中的复杂作用。
Oncol Lett. 2018 Mar;15(3):3403-3408. doi: 10.3892/ol.2018.7795. Epub 2018 Jan 15.